244 related articles for article (PubMed ID: 6157650)
21. [Tumor markers in testicular tumors].
Jibiki K; Odagiri E; Demura R; Demura H; Yamaguchi Y
Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
23. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Jacobsen GK
Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):183-90. PubMed ID: 6190351
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry of germ cell tumors of the testis. Study of beta HCG and AFP.
Caillaud JM; Bellet D; Carlu C; Droz JP
Prog Clin Biol Res; 1985; 203():139-40. PubMed ID: 2421327
[No Abstract] [Full Text] [Related]
26. [Tumor marker in urology].
Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
[TBL] [Abstract][Full Text] [Related]
27. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic progress in testicular carcinoma].
Aiginger P; Kolbe H; Kühböck J; Spona J
Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
[TBL] [Abstract][Full Text] [Related]
29. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
[TBL] [Abstract][Full Text] [Related]
30. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
Javadpour N; Soares T
Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
[TBL] [Abstract][Full Text] [Related]
31. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
Lange PH; Hakala TR; Fraley EE
Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
[No Abstract] [Full Text] [Related]
32. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
[TBL] [Abstract][Full Text] [Related]
33. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
Wittekind C; Wichmann T; Von Kleist S
Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
[TBL] [Abstract][Full Text] [Related]
34. [Testis cancer markers. Clinical use].
Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
[TBL] [Abstract][Full Text] [Related]
36. Detection of beta-human chorionic gonadotropin expressing cells by nested reverse transcriptase-polymerase chain reaction in the peripheral blood stem cells of patients with advanced germ cell tumor.
Hara I; Yamada Y; Miyake H; Hara S; Gotoh A; Fujisawa M; Okada H; Arakawa S; Kamidono S
J Urol; 2002 Mar; 167(3):1487-91. PubMed ID: 11832775
[TBL] [Abstract][Full Text] [Related]
37. Tumor markers in testicular cancer.
Catalona WJ
Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
[TBL] [Abstract][Full Text] [Related]
38. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
39. Potential therapeutic and diagnostic applications of the growth of testicular cancer in soft agar.
Foster BJ; Javadpour N; Ozols RF
Int J Cell Cloning; 1983 Apr; 1(1):2-14. PubMed ID: 6201566
[TBL] [Abstract][Full Text] [Related]
40. Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
Mann K; Lamerz R; Hellmann T; Kümper HJ; Staehler G; Karl HJ
Oncodev Biol Med; 1980; 1(4-5):301-12. PubMed ID: 6169065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
